Hypothesis

TET enzyme decline creates a measurable increase in epigenetic entropy that propagates through hierarchical gene‑regulatory networks, converting a stochastic loss of 5hmC into coordinated dysregulation of immune function, stem cell exhaustion, inflammation and proteostasis.

Mechanistic Model

Age‑related linear loss of TET1/TET3 in peripheral blood mononuclear cells reduces global 5hmC and stalls the oxidation of 5mC to 5caC. The resulting accumulation of 5caC interferes with TDG‑dependent base excision repair, causing persistent abasic sites that trigger replication stress during hematopoietic proliferation. Replication stress activates ATR‑CHK1 signaling, which phosphorylates histone H2AX and sustains a chromatin state permissive for NF‑κB transcriptional activity. Concurrently, reduced 5hmC at enhancers of antioxidant genes (e.g., SOD2, GPX4) diminishes their occupancy by TFAP2C, lowering transcriptional output and elevating mitochondrial ROS. Elevated ROS further oxidizes TET Fe(II) cofactors, creating a positive feedback loop that accelerates 5hmC loss. The combined effect is a shift in network connectivity: eigen‑directions associated with DNA‑damage response and inflammatory signaling gain heightened sensitivity, while those governing lysosomal proteostasis and ribosome biogenesis lose resilience. This redistribution of vulnerability explains why multiple hallmarks appear concurrently without requiring a single master switch.

Testable Predictions

1. Rescue experiment – Lentiviral overexpression of wild‑type TET1 in aged human CD34+ hematopoietic stem cells will restore 5hmC levels, reduce 5caC accumulation, decrease γH2AX foci after ex vivo replication stress, and lower secretion of IL‑6 and TNF‑α upon LPS challenge compared with empty vector controls.
2. Catalytically dead control – Expression of a TET1 HxD mutant (catalytically inactive) will not rescue 5hmC, will maintain high 5caC, and will exacerbate replication stress markers and SASP factors, confirming that enzymatic activity is required.
3. Pharmacological modulation – Treatment of aged mice with the TET activator vitamin C (ascorbate) in drinking water for 8 weeks will increase blood 5hmC, decrease plasma 5caC, improve neutrophil phagocytic capacity, and reduce frailty index scores relative to vehicle‑treated littermates.
4. Network read‑out – Single‑cell multi‑omics (scATAC‑seq + scRNA‑seq) from young and old mice treated with TET activator will show a specific re‑wiring of chromatin accessibility at DNA‑repair and inflammatory gene loci, with a concomitant shift in the leading eigenvectors of the gene‑regulatory network toward a youthful configuration.

Falsifiability

If overexpression of TET1 fails to reduce 5caC or does not alleviate replication stress‑associated γH2AX despite restoring 5hmC, or if vitamin C supplementation does not improve any functional aging readout, the hypothesis that TET-mediated epigenetic entropy drives the coordinated decline of hallmarks would be refuted. Conversely, confirmation of the predicted molecular and phenotypic changes would support the model that TET activity serves as a network‑level regulator whose deterioration propagates aging across scales.